Signal active
Organization
Contact Information
Overview
Qubit Pharmaceuticals is a brand-new international company based in Paris that was founded by CNAM, CNRS, the University of Texas at Austin, the Sorbonne University, and Washington University. Qubit Pharmaceuticals is built on more than 20 years of R and D that has been recognized with the most prestigious awards. It was founded by Pr Jay Ponder, Pr Pengyu Ren, Pr J.-P. Piquemal, Dr Louis Lagardere, and Pr Matthieu Montes.
About
Biotechnology
2020
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Qubit Pharmaceuticals headquartered in Europe, operates in the Biotechnology sector. The company focuses on Biotechnology and has secured $159.5M in funding across 8 round(s). With a team of 11-50 employees, Qubit Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Qubit Pharmaceuticals, raised $3.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
2
1
0
$19.9M
Details
1
Qubit Pharmaceuticals has raised a total of $19.9M in funding over 1 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2022 | Seed | 16.9M |
Investors
Qubit Pharmaceuticals is funded by 8 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Qubit Pharmaceuticals | - | FUNDING ROUND - Qubit Pharmaceuticals | 16.9M |
European Innovation Council | - | FUNDING ROUND - European Innovation Council | 16.9M |
Qubit Pharmaceuticals | - | FUNDING ROUND - Qubit Pharmaceuticals | 3.0M |
European Innovation Council | - | FUNDING ROUND - European Innovation Council | 3.0M |
Recent Activity
There is no recent news or activity for this profile.